BRPI0908114A2 - tabuleta oral de liberação controlada - Google Patents
tabuleta oral de liberação controladaInfo
- Publication number
- BRPI0908114A2 BRPI0908114A2 BRPI0908114A BRPI0908114A BRPI0908114A2 BR PI0908114 A2 BRPI0908114 A2 BR PI0908114A2 BR PI0908114 A BRPI0908114 A BR PI0908114A BR PI0908114 A BRPI0908114 A BR PI0908114A BR PI0908114 A2 BRPI0908114 A2 BR PI0908114A2
- Authority
- BR
- Brazil
- Prior art keywords
- controlled release
- release oral
- oral tablet
- tablet
- controlled
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 title 1
- 239000007935 oral tablet Substances 0.000 title 1
- 229940096978 oral tablet Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN339MU2008 | 2008-02-15 | ||
PCT/IN2009/000106 WO2009122431A2 (en) | 2008-02-15 | 2009-02-16 | Oral controlled release tablet |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0908114A2 true BRPI0908114A2 (pt) | 2015-10-06 |
Family
ID=40955347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0908114A BRPI0908114A2 (pt) | 2008-02-15 | 2009-02-16 | tabuleta oral de liberação controlada |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090208572A1 (pt) |
EP (1) | EP2242485A4 (pt) |
JP (1) | JP2011512349A (pt) |
KR (1) | KR20100136967A (pt) |
CN (1) | CN102026628A (pt) |
BR (1) | BRPI0908114A2 (pt) |
CA (1) | CA2715584A1 (pt) |
MX (1) | MX2010008861A (pt) |
WO (1) | WO2009122431A2 (pt) |
ZA (1) | ZA201006793B (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7465456B2 (en) * | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
US8012736B2 (en) * | 2002-04-26 | 2011-09-06 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
TWI331803B (en) | 2002-08-19 | 2010-10-11 | Univ Columbia | A single-shot semiconductor processing system and method having various irradiation patterns |
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
EP1697521B1 (en) * | 2003-12-23 | 2010-06-02 | MedImmune, LLC | Multi plasmid system for the production of influenza virus |
JP5666905B2 (ja) * | 2007-06-18 | 2015-02-12 | メディミューン,エルエルシー | ヘマグルチニンポリペプチド中に変化を有するインフルエンザbウイルス |
US8956654B2 (en) | 2009-06-02 | 2015-02-17 | Dow Global Technologies Llc | Sustained release dosage form |
US20120207825A1 (en) * | 2009-09-17 | 2012-08-16 | Sunilendu Bhushan Roy | Pharmaceutical compositions for reducing alcohol-induced dose dumping |
EP2488029B1 (en) * | 2009-09-30 | 2016-03-23 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
US20120328697A1 (en) * | 2011-06-01 | 2012-12-27 | Fmc Corporation | Controlled Release Solid Dose Forms |
CN104968333B (zh) | 2012-11-30 | 2018-07-10 | 阿库拉制药公司 | 活性药物成分的自调节释放 |
US9675587B2 (en) | 2013-03-14 | 2017-06-13 | Allergan Holdings Unlimited Company | Opioid receptor modulator dosage formulations |
JP5941117B2 (ja) * | 2014-10-17 | 2016-06-29 | ダウ グローバル テクノロジーズ エルエルシー | 徐放製剤 |
WO2017040607A1 (en) | 2015-08-31 | 2017-03-09 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
EA030138B1 (ru) * | 2016-06-15 | 2018-06-29 | Общество С Ограниченной Ответственностью "Фармадиол" | Фармацевтические композиции, включающие антикоагулянт n-(5-хлорпиридин-2-ил)-2-({4-[этанимидоил(метил)амино]бензоил}амино)-5-метилбензамид |
IT201800011125A1 (it) * | 2018-12-14 | 2020-06-14 | Dpl Pharma S P A | Composizioni farmaceutiche orali solide comprendenti matrici monolitiche complesse per la somministrazione cronotropica di medicamenti nel tratto gastroenterico |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4519801A (en) * | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
US4693896A (en) * | 1985-10-07 | 1987-09-15 | Fmc Corporation | Ethylcellulose-coated, gastric-disintegrable aspirin tablet |
IT1188212B (it) * | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
US5271946A (en) * | 1988-04-20 | 1993-12-21 | Asta Pharma Aktiengesellschaft | Controlled release azelastine-containing pharmaceutical compositions |
IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Hydrogel-operated release devices |
IT1237904B (it) * | 1989-12-14 | 1993-06-18 | Ubaldo Conte | Compresse a rilascio a velocita' controllata delle sostanze attive |
KR100205276B1 (ko) * | 1991-10-04 | 1999-07-01 | 가마쿠라 아키오 | 서방성 정제 |
ATE195252T1 (de) * | 1993-04-23 | 2000-08-15 | Novartis Erfind Verwalt Gmbh | Wirkstoffabgabevorrichtung mit gesteuerter freigabe |
ES2065313T5 (es) * | 1993-05-15 | 2004-01-01 | Roche Diagnostics Gmbh | Tableta con biodisponibilidad mejorada que contiene acido diclorometilendifosfonico como sustancia activa. |
IT1264517B1 (it) * | 1993-05-31 | 1996-09-24 | Ekita Investments Nv | Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
IT1282576B1 (it) * | 1996-02-06 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili |
EP0951279A1 (en) * | 1997-01-10 | 1999-10-27 | Abbott Laboratories | Tablet for the controlled release of active agents |
US20010055613A1 (en) * | 1998-10-21 | 2001-12-27 | Beth A. Burnside | Oral pulsed dose drug delivery system |
US6706283B1 (en) * | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
CA2395333C (en) * | 1999-12-23 | 2009-01-13 | Pfizer Products Inc. | Hydrogel-driven drug dosage form |
US6720005B1 (en) * | 2000-07-07 | 2004-04-13 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Coated, platform-generating tablet |
US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
IL159715A0 (en) * | 2001-07-10 | 2004-06-20 | Teva Pharma | Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
GB0117618D0 (en) * | 2001-07-19 | 2001-09-12 | Phoqus Ltd | Pharmaceutical dosage form |
ITMI20020514A1 (it) * | 2002-03-12 | 2003-09-12 | Jagotec Ag | Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi |
ITMI20020515A1 (it) * | 2002-03-12 | 2003-09-12 | Jagotec Ag | Sistema per il rilasco controllato di uno o piu' principi attivi |
WO2004108067A2 (en) * | 2003-04-03 | 2004-12-16 | Sun Pharmaceutical Industries Limited | Programmed drug delivery system |
US7314640B2 (en) * | 2003-07-11 | 2008-01-01 | Mongkol Sriwongjanya | Formulation and process for drug loaded cores |
US8163306B2 (en) * | 2003-09-19 | 2012-04-24 | Sun Pharma Advanced Research Company | Oral drug delivery system |
WO2006094083A1 (en) * | 2005-02-28 | 2006-09-08 | Penwest Pharmaceuticals Co. | Controlled release venlafaxine formulations |
JP5020931B2 (ja) * | 2005-03-14 | 2012-09-05 | サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド | 経口薬剤送達システム |
CA2611081C (en) * | 2005-06-03 | 2016-05-31 | Egalet A/S | A drug delivery system for delivering active substances dispersed in a dispersion medium |
PL116330U1 (en) * | 2005-10-31 | 2007-04-02 | Alza Corp | Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation |
WO2007057762A2 (en) * | 2005-11-16 | 2007-05-24 | Pfizer Limited | Osmotic bi-layer tablet |
US20070264346A1 (en) * | 2006-02-16 | 2007-11-15 | Flamel Technologies | Multimicroparticulate pharmaceutical forms for oral administration |
-
2009
- 2009-02-16 KR KR1020107019012A patent/KR20100136967A/ko not_active Application Discontinuation
- 2009-02-16 JP JP2010546446A patent/JP2011512349A/ja active Pending
- 2009-02-16 BR BRPI0908114A patent/BRPI0908114A2/pt not_active IP Right Cessation
- 2009-02-16 EP EP09727912.9A patent/EP2242485A4/en not_active Withdrawn
- 2009-02-16 CA CA2715584A patent/CA2715584A1/en not_active Abandoned
- 2009-02-16 CN CN2009801103021A patent/CN102026628A/zh active Pending
- 2009-02-16 MX MX2010008861A patent/MX2010008861A/es not_active Application Discontinuation
- 2009-02-16 WO PCT/IN2009/000106 patent/WO2009122431A2/en active Application Filing
- 2009-02-17 US US12/372,161 patent/US20090208572A1/en not_active Abandoned
-
2010
- 2010-09-22 ZA ZA2010/06793A patent/ZA201006793B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201006793B (en) | 2011-05-25 |
MX2010008861A (es) | 2011-02-22 |
EP2242485A4 (en) | 2013-05-08 |
EP2242485A2 (en) | 2010-10-27 |
CN102026628A (zh) | 2011-04-20 |
WO2009122431A3 (en) | 2010-01-07 |
KR20100136967A (ko) | 2010-12-29 |
US20090208572A1 (en) | 2009-08-20 |
CA2715584A1 (en) | 2009-10-08 |
WO2009122431A2 (en) | 2009-10-08 |
JP2011512349A (ja) | 2011-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0908114A2 (pt) | tabuleta oral de liberação controlada | |
BR112012011733A2 (pt) | formulações de comprimido de liberação imediata | |
HK1216232A1 (zh) | 控釋藥物組合物 | |
IL237391A0 (en) | Pharmaceutical combination | |
DK3090730T3 (da) | Tabletter omfattende eltrombopag-olamin | |
BRPI1013622A2 (pt) | cápsula liberadora | |
BRPI1014085A2 (pt) | comprimido revestido de desintegração oral | |
BRPI0820861A2 (pt) | Comprimido oral dispersível | |
BRPI0808889A2 (pt) | Comprimido desintegrante oral | |
FI20085277A0 (fi) | Kohdunsisäinen järjestelmä | |
IL207378A0 (en) | Pharmaceutical solid state forms | |
NO20083238L (no) | Narresmokk | |
BR112012002271A2 (pt) | cápsulas de liberação sustentada | |
BRPI0812916A2 (pt) | Chupeta | |
BRPI0906754A2 (pt) | Formulário de dosage prolongado da libertação de paliperidone | |
BRPI0922423A2 (pt) | dispositivo de liberação de fármaco | |
BRPI0912428A2 (pt) | formulação farmacêutica sólida de liberação retardada | |
DK2271618T3 (da) | Farmaceutiske forbindelser | |
DK2272763T3 (da) | Blisterpakning-dispensermaskine | |
EP2145884A4 (en) | INDOLEDIONDERIVAT | |
HK1152640A1 (en) | Pharmaceutical combination | |
BRPI0913425A2 (pt) | formulações de niacina com liberação modificada | |
BRPI0823402A2 (pt) | Formulações farmacêuticas de olmesartan | |
BRPI0922623A2 (pt) | comprimido farmacêutico de liberação controlada | |
UY33127A (es) | Formulación de liberación sostenida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |